Literature DB >> 2184681

Endotoxin inhibits contraction of vascular smooth muscle in vitro.

D Beasley1, R A Cohen, N G Levinsky.   

Abstract

Decreased responsiveness of the vasculature to vasoconstrictors has been implicated in the pathogenesis of endotoxic shock, yet the mechanism of diminished responsiveness has not been determined. In these studies, exposure of rat aortic rings to purified Escherichia coli lipopolysaccharide (endotoxin) in vitro inhibited subsequent contractions caused by vasoconstrictors. Contractions caused by the alpha-adrenoceptor agonist phenylephrine, as well as those induced by potassium depolarization, were depressed by endotoxin. The effect of endotoxin on vascular contractions was delayed. Phenylephrine-induced contractions were not decreased during a 1-h exposure to endotoxin (10 micrograms/ml), but they were markedly decreased when tested several hours after the exposure period. A large part of the inhibition caused by a 1-h exposure to endotoxin was endothelium dependent. In contrast, endotoxin inhibited contractions equally in rings with or without endothelium exposed to endotoxin for a longer period (3 h). The inhibitory effect of endotoxin was not affected by indomethacin, but it was eliminated in aortic rings treated with the protein synthesis inhibitor cycloheximide. These studies indicate that endotoxin potently inhibits vascular contraction in vitro. The effect of endotoxin is apparently independent of prostanoids but may involve protein synthesis and effects on both vascular smooth muscle and endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2184681     DOI: 10.1152/ajpheart.1990.258.4.H1187

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

1.  Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve.

Authors:  D Annane; E Bellissant; V Sebille; O Lesieur; B Mathieu; J C Raphael; P Gajdos
Journal:  Br J Clin Pharmacol       Date:  1998-12       Impact factor: 4.335

2.  Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14.

Authors:  H Loppnow; F Stelter; U Schönbeck; C Schlüter; M Ernst; C Schütt; H D Flad
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

3.  Systemic pressure-flow reactivity to norepinephrine in rabbits: impact of endotoxin and fluid loading.

Authors:  A Ricard-Hibon; M R Losser; R Kong; S Beloucif; B Teisseire; D Payen
Journal:  Intensive Care Med       Date:  1998-09       Impact factor: 17.440

4.  Effect of endotoxin on the angiotensin II receptor in cultured vascular smooth muscle cells.

Authors:  M Burnier; G Centeno; G Waeber; C Centeno; E Bürki
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

5.  The role of nitric oxide in the responses of the ovine digital artery to vasoactive agents and modification of these responses by endotoxin and cytokines.

Authors:  P Pawson; J Reid; A M Nolan
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

6.  Impaired vascular sensitivity to nitric oxide in the coronary microvasculature after endotoxaemia.

Authors:  R G Bogle; P G McLean; A Ahluwalia; P Vallance
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

Review 7.  Respiratory muscle dysfunction in sepsis.

Authors:  S N Hussain
Journal:  Mol Cell Biochem       Date:  1998-02       Impact factor: 3.396

Review 8.  The role of CD14 and lipopolysaccharide-binding protein (LBP) in the activation of different cell types by endotoxin.

Authors:  R R Schumann; E T Rietschel; H Loppnow
Journal:  Med Microbiol Immunol       Date:  1994-12       Impact factor: 3.402

9.  Increased intracellular Ca2+: a critical link in the pathophysiology of sepsis?

Authors:  S K Song; I E Karl; J J Ackerman; R S Hotchkiss
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

10.  The role of induction of nitric oxide synthesis in the altered responses of jugular veins from endotoxaemic rabbits.

Authors:  P Vallance; R M Palmer; S Moncada
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.